Palmitoyl Tripeptide-1

Plamed Vision: Become the leader of natural cosmetic ingredients for sensitive skin.

Palmitoyl Tripeptide-1

Palmitoyl Tripeptide-1, also known as Palmitoyl Oligopeptide, is a classic collagen-promoting signal peptide and a core active ingredient for root-cause anti-aging, firming and wrinkle-reducing skincare.

Cosmetic-grade Palmitoyl Tripeptide-1 is chemically synthesized in compliance with regulations. Plamed produces the ingredient via Solid Phase Peptide Synthesis (SPPS), stably supplying high-purity ≥98.0%; the internal control standard for active peptide content is ≥80.0%, with batch test values reaching up to 85.1%.

Chloride ions may derive from salt formation adjustment and neutralization during peptide manufacturing, existing in various forms in the system. Plamed has established a scientific chloride content control range, optimizing the industry’s conventional free hydrochloric acid detection index. Traditional hydrochloric acid content is calculated indirectly via chloride conversion, involving salt-form assumptions and conversion errors. Based on analysis of potential salt-forming sites of Palmitoyl Tripeptide-1, we set a reasonable control range with reference to the theoretical maximum salt-forming chloride content for batch stability management. This indicator is accurate and unambiguous, helping reduce formulation fluctuation risks, shorten formulation adjustment cycles, and improve formulation development efficiency and long-term finished product stability.

As a classic Matrikine-mimetic peptide, Palmitoyl Tripeptide-1 simulates active fragments released during collagen degradation (represented by type I collagen-related signal sequences), sending “collagen regeneration” signals to skin fibroblasts and triggering the self-repair mechanism of the dermis. It regulates collagen synthesis-related signaling pathways such as TGF-β/Smad, enhances fibroblast activity, and upregulates the expression of key extracellular matrix (ECM) components, including type I/III collagen, elastin, fibronectin and glycosaminoglycans. It also helps regulate matrix metalloproteinase (MMPs) activity to reduce excessive collagen degradation, forming a two-way regulatory mechanism of “promoting synthesis + inhibiting degradation”, thereby improving the structural integrity and stability of the dermis.

In addition, by promoting ECM reconstruction, it improves the skin microenvironment, indirectly optimizes keratinocyte function, upregulates the expression of barrier-related proteins (e.g., filaggrin), strengthens skin barrier integrity, and reduces transepidermal water loss (TEWL).

With its signal-activated anti-aging mechanism, Palmitoyl Tripeptide-1 fundamentally improves dry lines, fine lines, skin sagging and loss of elasticity caused by collagen loss, achieving comprehensive effects including wrinkle reduction, firming, structural support enhancement and photoaging repair. It is widely used in high-end anti-aging, firming, wrinkle-reducing and barrier-repairing skincare products.

Product Name CAS INCI
Palmitoyl Tripeptide-1 147732-56-7 Palmitoyl Tripeptide-1
Molecular Formula Molecular Weight Molecular Structure
C30H54N6O5 578.8g/mol
Product ID Specification Minimal Package MOQ
PMKZ3001 Purity≥98%

Peptide content≥80%

10g 10g

Palmitoyl Tripeptide-1 is chemically synthesized, mainly via Solid Phase Peptide Synthesis (SPPS) and Liquid Phase Peptide Synthesis (LPPS).

Plamed has achieved breakthroughs in scientific chloride content control, high purity, high active peptide content and low impurity residue, meeting the compliance, efficacy and global promotion requirements of high-end cosmetic raw materials.

Item Solid Phase Peptide Synthesis (SPPS) Liquid Phase Peptide Synthesis (LPPS)
Production Process Raw materials-Synthesis-Purification- Drying-Packaging Multi-step amino acid coupling, deprotection, stepwise extraction and purification, freeze-drying and refining in pure liquid phase
Advantages High active content: HPLC purity ≥98%, active peptide content ≥80% (up to 85.1%), far exceeding industry average.

Low impurities, high stability: low moisture and chloride impurities, not easy to degrade.

Full-process controllable: 100% pure active powder, no solvent dilution, precise formulation addition

Low raw material cost, high flexibility for small-batch custom synthesis, suitable for short peptides and small molecule fragments
Disadvantages Higher synthesis cost than LPPS, high technical requirements Complex synthesis steps, difficult purity control, high large-scale production cost
TEST ITEMS SPECIFICATION
Purity ≥98.0% HPLC
Peptide content ≥80.0% HPLC
Chloride content ≤15.0%
Organoleptic
Appearance Powder
Color White to off-white
Odor Characteristic
Physical Characteristics
Water content ≤8.0%
Heavy Metal
Pb ≤10ppm
As ≤2ppm
Hg ≤1ppm
Cd ≤5ppm
Microorganism Test
Total plate count ≤1000 cfu/g
Yeast & mold count ≤100 cfu/g

Collagen Promotion, Wrinkle Reduction & Firming

As a classic collagen-promoting signal peptide (Matrikine), it mimics signal fragments generated during ECM degradation, sends “collagen regeneration” signals to fibroblasts, regulates TGF-β/Smad pathways, upregulates the expression of type I/III collagen, elastin, fibronectin and glycosaminoglycans. It supports dermal structural integrity and density, fills dry lines and fine lines, improves sagging, and enhances skin firmness and elasticity.

Anti-Photoaging

UV-induced photoaging is a major driver of extrinsic skin aging, causing oxidative stress, inflammation, increased collagen degradation and damaged elastic fibers, leading to wrinkles, roughness and dullness.

Palmitoyl Tripeptide-1 exerts anti-photoaging effects via structural support + microenvironment regulation: it reduces UV-induced ROS and inflammation, downregulates MMPs to slow collagen/elastin degradation, promotes ECM synthesis and metabolic balance, maintaining dermal stability and delaying photoaging-related structural deterioration.

Barrier Repair & ECM Improvement

It promotes ECM reconstruction, optimizes skin microenvironment and keratinocyte function, upregulates filaggrin, loricrin and other barrier proteins, reduces TEWL, strengthens the skin barrier fundamentally, and improves resistance to external irritants, suitable for damaged skin repair.

Synergistic Anti-Aging with Palmitoyl Tetrapeptide-7

Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7 have highly complementary mechanisms, forming a dual-pathway anti-aging closed loop of structural construction + inflammation inhibition, with excellent performance in wrinkle improvement, elasticity enhancement and texture optimization.

Palmitoyl Tripeptide-1 (Construction): Stimulates fibroblasts to synthesize new collagen, elastin and ECM, building a youthful dermal structure and filling lines.

Palmitoyl Tetrapeptide-7 (Protection): Regulates inflammation pathways (e.g., NF-κB), reduces pro-inflammatory factors, downregulates MMPs, blocks collagen degradation and protects dermal integrity.

  • Scientific Chloride Content Control: Based on salt-forming site analysis, a reasonable control system is established with reference to theoretical maximum salt-forming chloride content, ensuring small batch-to-batch variation, reducing formulation adjustment cost and shortening development cycle. Compatible with all dosage forms, strong ion tolerance, no impact on thickening and emulsification systems.
  • 100% Pure Active Powder: No solvent dilution, flexible formulation, cost-effective, no solvent interference.
  • High Purity & High Activity:HPLC purity ≥98.0% (tested up to 98.9%), peptide content ≥80.0% (tested up to 85.1%), superior to industry standards, high efficacy at low cost.
  • Low Impurities & High Stability:Strict impurity control, not easy to degrade, ensuring long-term stability of final formulations.

Palmitoyl Tripeptide-1 achieves anti-aging effects at low addition levels, widely used in high-end anti-aging wrinkle serums, firming creams, eye care, anti-photoaging products, barrier-repair emulsions and other full-category skincare products.

Product and specification Reference Dosage
Palmitoyl Tripeptide-1 (Purity ≥98.0%) 0.001–0.1%

Notes:

  • Not compatible with strong acids, strong alkalis, strong oxidizers, acyl chlorides and acid anhydrides.
  • Store unopened raw material sealed at 2-8°C (no -20°C ultra-low temperature required); use promptly after opening to avoid moisture absorption and microbial contamination.
  • Recommended to combine with Palmitoyl Tetrapeptide-7 for synergistic anti-aging.
  • Add to cosmetic formulations below 45°C at the final stage.

Application Cases in Major Global Cosmetic Brands

Country Brand Product
China PROYA Energizing Fresh Anti-Wrinkle Firming Eye Cream

Time Reset Firming Sculpting Cream

INOHERB Rhodiola Brightening Essence
USA

 

LA MER The Lifting Firming Night Cream
Elizabeth Arden RETINOL + HPR Ceramide Capsules Line Erasing Night Serum
Kiehl’s Better Screen UV Serum
France

 

Clarins Double Serum LIGHT TEXTURE Complete Age Control Concentrate
L’Oréal Paris Age Perfect Nectar Collagen Nourishing Cream

Age Perfect Nectar Collagen Essence Water

Revitalift Filler Hyaluronic Acid Anti-Wrinkle Eye Cream

CHANEL N°1 DE CHANEL SÉRUM REVITALISANT AU CAMÉLIA ROUGE
Japan Shiseido Benefiance Wrinkle Smoothing Eye Cream
South Korea Ongredients Skin Barrier Calming Lotion

  • Palmitoyl Tripeptide-1 is listed in the “List of Cosmetic Ingredients in Use (2021 Edition)” issued by the China National Medical Products Administration (NMPA).
  • Palmitoyl Tripeptide-1 is registered as a compliant cosmetic raw material by PCPC (USA) and Cosing (EU).
  • Palmitoyl Tripeptide-1 shows good skin tolerance under recommended usage: low irritation, sensitization and phototoxicity risks. No significant adverse reactions reported at 0.001–0.1% cosmetic concentration.

Packaging: 10 g pharmaceutical bottle, sealed with sterile aluminum foil inside.

Storage: Sealed and stored at 2–8°C.

Data/Report Center

Click the button to get the full product report.